ALLMedicine™ Type 2 Diabetes Center

Aug 10th, 2022 - This review aims to discuss the potential roles of omega-3 (ω-3) and omega-6 (ω-6) polyunsaturated fatty acids (PUFAs) in the prevention and treatment of metabolic diseases, to provide the latest evidence from epidemiological and clinical studies,...

Aug 10th, 2022 - Cardiovascular disease remains one of the leading causes of morbidity and mortality today. The major risk factors for cardiovascular disease include type 2 diabetes mellitus, hypertension, tobacco smoking, elevated body mass index, and hyperlipide...

Aug 10th, 2022 - To identify population with type 2 diabetes mellitus (T2DM) who are more likely to benefit from switching to basal insulin (BI) treatment from premixed insulin. This secondary analysis included data from a previously published study (Optimization:...

Aug 10th, 2022 - Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure.|2022|Narkiewicz K,Kjeldsen SE,Egan BM,Kreutz R,Burnier M,|

Aug 10th, 2022 - Obesity is associated with the infiltration of monocytes/macrophages into adipose tissue in which MCP-1 plays a crucial role. But the regulatory mechanism of MCP-1 expression in adipocytes is not well defined. Our results demonstrated that TNF-α i...

Jul 17th, 2022 - Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading etiology for chronic liver disease, affecting >25% of the US and global populations. Up to 1 in 4 individuals with NAFLD have nonalcoholic steatohepatitis, which is associate...

May 16th, 2022 - To provide evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other...

Jan 24th, 2022 - Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However, quantifiable risk-factors for PASC and their biological associations are poorly resolved. We executed a deep multi-omic, longitudinal investigation of 309 COVID-1...

Jan 15th, 2022 - This consensus statement is an update of the 2010 American College of Sports Medicine position stand on exercise and type 2 diabetes. Since then, a substantial amount of research on select topics in exercise in individuals of various ages with typ...

Jan 5th, 2022 - People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney disease (CKD) and end-stage kidney failure. Hypertension is a major, reversible risk factor in people with diabetes for development of albuminuria, impaire...

Aug 5th, 2022 - The Specific Aims of the first phase of the study are as follows: Aim 1. To determine the feasibility of performing a randomized trial comparing two major types of bariatric surgery, Laparoscopic Roux en Y Gastric Bypass (RNY) and Laparoscopic Adj...

Aug 5th, 2022 - Approximately 50% of Pima Indian children from diabetic pregnancies develop T2DM by age 25. Since intrauterine exposure to diabetes leads to a higher risk of diabetes in the offspring, the risk might be greatly diminished by preventing diabetes du...

Aug 5th, 2022 - The purpose of this study is to evaluate the efficacy and safety of Berlim 25/10 association in the treatment of type 2 diabetes mellitus and dyslipidemia.

Aug 5th, 2022 - The purpose of this study is to evaluate the efficacy and safety of Madalena association in the treatment of type 2 diabetes mellitus.

Aug 5th, 2022 - Growing evidences have pointed to the role of 5-lipooxygenase / leukotriene pathway in the pathogenesis of diabesity. Cysteinyl leukotrienes (Cys-LT) are potent inflammatory lipid mediators derived from the 5-lipoxygenase pathway of arachidonic ac...

Aug 11th, 2022 - The study covered in this summary was published in Preprints for Research Square as a preprint and has not yet been peer reviewed. Key Takeaways South Asians dying with atherosclerosis in the United States were twice as likely to have concurrent d...

Aug 9th, 2022 - Strasbourg, France — An international team coordinated by researcher Vincent Marion, PhD, deputy director of the French National Institute of Health and Medical Research (Inserm)/University of Strasbourg Medical Genetics Laboratory, has published ...

Aug 8th, 2022 - The glucagon-like peptide-1 (GLP-1) agonist semaglutide formulated for treating obesity (Wegovy) had a roaring takeoff a little more than a year ago, with surging patient demand after the US Food and Drug Administration (FDA) approved it in June 2...

Aug 5th, 2022 - Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed. Key Takeaways The results showed a 58% prevalence of euthyroid sick syndrome (ESS) in 396 adults hospitalized with diabet...

Aug 4th, 2022 - Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed. Key Takeaways Older patients (65 years and older) with type 2 diabetes and decreased intrinsic capacity (a measure of phy...